Inhibrx Biosciences, Inc. (NASDAQ:INBX) Stock Has Consensus Price Target of $197.50
Inhibrx Biosciences, Inc. (NASDAQ:INBX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and one […]
6 Oct 05:14 · The Markets Daily